This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Lg Life Sciences, Limited. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Tae-Sik Kwon: Innovator in Caspase Inhibition
Introduction
Tae-Sik Kwon is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic agents. His work focuses on innovative solutions for preventing inflammation and apoptosis.
Latest Patents
One of Tae-Sik Kwon's notable patents is titled "Caspase inhibitors containing isoxazoline ring." This invention relates to an isoxazoline derivative that acts as an inhibitor against various caspases. The patent outlines a process for preparing the isoxazoline derivative and describes a therapeutic composition that utilizes this compound to prevent inflammation and apoptosis. He holds 1 patent in this area.
Career Highlights
Tae-Sik Kwon is currently employed at LG Life Sciences, Limited, where he continues to advance his research and development efforts. His work at the company has positioned him as a key player in the field of pharmaceutical innovation.
Collaborations
Some of his notable coworkers include Hye-Kyung Chang and Yeong-Soo Oh, who collaborate with him on various projects within the company.
Conclusion
Tae-Sik Kwon's contributions to the field of caspase inhibition highlight his innovative spirit and dedication to advancing medical science. His work not only showcases his expertise but also has the potential to impact therapeutic approaches in treating inflammation and apoptosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile